Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Orchids Paper Products CO (TISUQ)
|
Add to portfolio |
|
|
Price: |
$0.00
| | Metrics |
OS: |
10.7
|
M
| |
-36
|
% ROE
|
Market cap: |
$39.5
|
k
| |
-8
|
% ROIC
|
Net debt:
|
$183
|
M
| |
|
|
EV:
|
$183
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
($3.8)
|
M
| |
|
|
EBIT
|
($23.5)
|
M
| |
|
|
EPS |
($3.53)
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 |
Revenues | 186.7 | 162.5 | 164.5 | 168.4 | 142.7 | 116.4 | 100.8 | 97.8 |
Revenue growth | 14.9% | -1.2% | -2.3% | 18.0% | 22.6% | 15.4% | 3.0% | 5.8% |
Cost of goods sold | 189.1 | 153.8 | 134.3 | 137.9 | 116.0 | 88.5 | 78.3 | 81.9 |
Gross profit | -2.4 | 8.7 | 30.1 | 30.5 | 26.7 | 27.9 | 22.6 | 16.0 |
Gross margin | -1.3% | 5.4% | 18.3% | 18.1% | 18.7% | 24.0% | 22.4% | 16.3% |
Selling, general and administrative | 20.2 | 11.7 | 10.2 | 9.5 | 11.7 | 9.5 | 8.5 | 6.8 |
EBITA | -22.5 | -3.0 | 21.0 | 21.0 | 15.1 | 18.4 | 14.1 | 9.1 |
EBITA margin | -12.1% | -1.8% | 12.8% | 12.4% | 10.6% | 15.8% | 14.0% | 9.3% |
Amortization of intangibles | 0.9 | 0.9 | 1.2 | 1.5 | 0.8 | | | |
EBIT | -23.5 | -3.9 | 19.8 | 19.5 | 14.3 | 18.4 | 14.1 | 9.1 |
EBIT margin | -12.6% | -2.4% | 12.0% | 11.5% | 10.0% | 15.8% | 14.0% | 9.3% |
Pre-tax income | -40.8 | -8.8 | 17.2 | 19.6 | 13.9 | 18.2 | 13.4 | 8.5 |
Income taxes | -3.1 | -15.5 | 4.4 | 6.1 | 4.4 | 4.9 | 4.1 | 2.3 |
Tax rate | 7.6% | 175.6% | 25.6% | 30.9% | 31.7% | 26.9% | 30.9% | 27.4% |
Net income | -37.7 | 6.7 | 12.8 | 13.6 | 9.5 | 13.3 | 9.3 | 6.2 |
Net margin | -20.2% | 4.1% | 7.8% | 8.0% | 6.6% | 11.4% | 9.2% | 6.3% |
|
Diluted EPS | ($3.53) | $0.64 | $1.24 | $1.38 | $1.11 | $1.68 | $1.18 | $0.80 |
Shares outstanding (diluted) | 10.7 | 10.4 | 10.3 | 9.8 | 8.5 | 7.9 | 7.8 | 7.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|